Thomas Grant secures $2.18 million grant to pioneer protein-studying tool that could lead to new and personalized medicine.
Software observability platform Honeycomb launched a new suite of artificial intelligence-powered products on Thursday, designed to help developers detect performance anomalies, investigate issues ...
Artificial Intelligence (AI) is at the heart of the latest global transformation, not least within the biopharmaceutical industry. AI is already rapidly redefining how we discover and design biologics ...